These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5478542)

  • 21. Influence of convulsive therapy on 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogenous depression.
    Nordin G; Ottosson JO; Roos BE
    Psychopharmacologia; 1971; 20(4):315-20. PubMed ID: 5561655
    [No Abstract]   [Full Text] [Related]  

  • 22. Dementias, psychological tests, and neurotransmitters.
    Degrell I; Pék G; Nagy D; Nagy E; Hoyer S
    Arch Gerontol Geriatr; 1985 Dec; 4(4):365-71. PubMed ID: 2421656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid and brain of different rabbit breeds after treatment with probenecid.
    Andersson H; Roos BE
    J Pharm Pharmacol; 1972 Feb; 24(2):165-6. PubMed ID: 4401976
    [No Abstract]   [Full Text] [Related]  

  • 24. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
    Chase TN
    Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.
    Sjöström R; Roos BE
    Eur J Clin Pharmacol; 1972 Jun; 4(3):170-6. PubMed ID: 4655292
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate and amine metabolites in senile dementia: a combined trial and biochemical study.
    Shaw DM; Macsweeney DA; Johnson AL; O'Keeffe R; Naidoo D; Macleod DM; Jog S; Preece JM; Crowley JM
    Psychol Med; 1971 Feb; 1(2):166-71. PubMed ID: 5148767
    [No Abstract]   [Full Text] [Related]  

  • 30. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients.
    Mendels J; Frazer A; Fitzgerald RG; Ramsey TA; Stokes JW
    Science; 1972 Mar; 175(4028):1380-2. PubMed ID: 5059569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homovanillic and 5-hydroxyindoleacetic acids in cerebrospinal fluid after probenecid: measurement of brain monoamine oxidase inhibition in vivo.
    Forn J; Maling HM; Gessa GL
    Proc Soc Exp Biol Med; 1970 Apr; 133(4):1310-3. PubMed ID: 5440420
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain amines, and their acids in the cerebrospinal fluid.
    Can Med Assoc J; 1967 Mar; 96(9):550-1. PubMed ID: 6019357
    [No Abstract]   [Full Text] [Related]  

  • 33. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.
    Guldberg HC; Yates CM
    Br J Pharmacol Chemother; 1968 Jul; 33(3):457-71. PubMed ID: 5728318
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 37. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania.
    Dencker SJ; Malm U; Roos BE; Werdinius B
    J Neurochem; 1966 Dec; 13(12):1545-8. PubMed ID: 5962034
    [No Abstract]   [Full Text] [Related]  

  • 38. Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
    Naidu S; Narasimhachari N
    Ann Neurol; 1980 Oct; 8(4):445-7. PubMed ID: 6159821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.